Avodart as a Prevention of Prostate Cancer

Avodart (dutasteride) is a drug similar in its activity to finasteride (Proscar/Propecia), having almost identical areas of application. It has been approved to treating benign prostatic hyperplasia and is being studied for its use in the fight against male pattern baldness. The Korean clinical trial has been completed already more than a year ago but its results have not yet been released and therefore Avodart has not been approved for treating male form of hair loss. The main concern here is not its efficacy but its side effects. Many hair loss sufferers buy generic Avodart online and they have confirmed the fact that it is a more powerful pill than Propecia (finasteride) in promoting new hair growth.

The big question mark is its side effects, which are supposed to be more severe than for finasteride as dutasteride is a dual 5-alpha reductase inhibitor. A recent study of dutasteride by GlaxoSmithKline confirmed that Avodart (dutasteride) is effective in reducing the risk of prostate cancer, which makes it yet more similar to finasteride. Although there is no consensus among the doctors on whether dutasteride, or any other hormone-blocking substance, should be used for cancer prevention some doctors suggest it might be prudent to use dutasteride in some very high risk patients. Another finding of this study is an increased incidence of heart failure in patients treated by this drug, which needs further examination but does not add credibility to Avodart due to its already now long enough list of potential side effects.

Posted in: Medical treatments for baldness and in: Latest hair loss news and discoveries